Date published: 2025-9-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Nifurtimox (CAS 23256-30-6)

0.0(0)
Write a reviewAsk a question

Application:
Nifurtimox is a nitrofuran antiprotazoal
CAS Number:
23256-30-6
Molecular Weight:
287.29
Molecular Formula:
C10H13N3O5S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Nifurtimox is a nitrofuran compound widely studied for its mechanism of action involving the generation of reactive oxygen species (ROS) and its effects on cellular redox balance. The primary mechanism of nifurtimox involves its reduction by nitroreductase enzymes within the target organism, leading to the production of nitro anion radicals. These radicals subsequently react with molecular oxygen, generating superoxide anions and other reactive oxygen species. The accumulation of ROS causes oxidative stress, damaging vital cellular components such as DNA, proteins, and lipids, ultimately leading to cell death. In research contexts, nifurtimox is utilized to explore the molecular pathways of oxidative stress and its impact on cellular functions. Studies often investigate how cells respond to oxidative damage, including the activation of antioxidant defense mechanisms and repair pathways. Additionally, nifurtimox serves as a model compound for studying nitrofuran toxicity and its broader implications for environmental and toxicological research. The ability of nifurtimox to induce oxidative stress also makes it a valuable tool in cancer biology research, where it is used to understand how cancer cells handle oxidative damage compared to normal cells. Through these applications, nifurtimox contributes significantly to our understanding of oxidative stress, cellular defense mechanisms, and the broader implications of nitrofuran compounds in biological research.


Nifurtimox (CAS 23256-30-6) References

  1. Buthionine sulfoximine increases the toxicity of nifurtimox and benznidazole to Trypanosoma cruzi.  |  Faundez, M., et al. 2005. Antimicrob Agents Chemother. 49: 126-30. PMID: 15616285
  2. Metabolization of nifurtimox and benznidazole in cellular fractions of rat mammary tissue.  |  Bartel, LC., et al. 2010. Hum Exp Toxicol. 29: 813-22. PMID: 20150355
  3. Trypanosoma cruzi: a possible control of transfusion-induced Chagas' disease by phenolic antioxidants.  |  Letelier, ME., et al. 1990. Exp Parasitol. 71: 357-63. PMID: 2121515
  4. Nifurtimox Is Ineffective against Drug-Resistant Mycobacteria.  |  Ruth, MM., et al. 2017. Antimicrob Agents Chemother. 61: PMID: 28652235
  5. Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A review.  |  Arrúa, EC., et al. 2019. Acta Trop. 198: 105080. PMID: 31299283
  6. Nifurtimox Hampered the Progression of Astroglioma In vivo Via Manipulating the AKT-GSK3β axis.  |  Zhang, Q., et al. 2020. Curr Mol Med. 20: 723-732. PMID: 32271693
  7. Efficacy and Toxicity of Fexinidazole and Nifurtimox Plus Eflornithine in the Treatment of African Trypanosomiasis: A Systematic Review.  |  Hidalgo, J., et al. 2021. Cureus. 13: e16881. PMID: 34513456
  8. Nifurtimox for Treatment of Chagas Disease in Pediatric Patients: the Challenges of Applying Pharmacokinetic-Pharmacodynamic Principles to Dose Finding.  |  Stass, H., et al. 2022. AAPS J. 24: 92. PMID: 36002604
  9. Structural and Mechanistic Investigation of the Unusual Metabolism of Nifurtimox.  |  Lang, D., et al. 2022. Chem Res Toxicol. 35: 2037-2048. PMID: 36209416
  10. Selected Aspects of the Analytical and Pharmaceutical Profiles of Nifurtimox.  |  Moroni, AB., et al. 2023. J Pharm Sci. 112: 1523-1538. PMID: 36822273

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Nifurtimox, 5 mg

sc-212392
5 mg
$390.00